PATENT CLAIM ANALYSIS

Application Number: 15961733
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "433000"]

Abstract:
A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.

Claim (Index 1):
A drug delivery system for use in female contraception, comprising a subdermally implantable bioerodible pellet that provides for controlled release of a contraceptive agent throughout an extended drug delivery time period that ends with complete bioerosion of the pellet in situ, the pellet comprising an amount of the contraceptive agent that, following subdermal implantation of at least one pellet into a female subject, results in a serum level of the contraceptive agent sufficient to achieve contraceptive efficacy during the extended drug delivery time period, wherein the extended drug delivery time period comprises:\n (a) an effective drug delivery time period in the range of about six months to about four years during which the active agent is released at a dosage sufficient to provide contraceptive efficacy, and thereafter (b) a sub-effective drug delivery tail period of at most about 12 months ending with complete bioerosion of the pellet, wherein during the tail period, the pellet continues to release the contraceptive agent but at a dosage below that necessary to provide contraceptive efficacy.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 1.6
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15720845', '15720921', '12234261', '13644929', '10592725']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6996182352643467
- 35 USC 102 Novelty (BERT): 0.6376584123981167
- Combined Prediction Score: 0.6934222529777238
- Mean Citation Score: 339.202132
- Max Citation Score: 618.0106
- Similarity Product: 560.8210251116632

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test